Home / News & Media » Orange Regional Medical Center Among the First Hospitals in the Hudson Valley to Implant Subcutaneous Implantable Defibrillator System (S-ICD®) + share

Orange Regional Medical Center Among the First Hospitals in the Hudson Valley to Implant Subcutaneous Implantable Defibrillator System (S-ICD®)

June 26, 2014

Middletown, NY – Orange Regional Medical Center is among the first of hospitals in the Hudson Valley to implant the entirely subcutaneous ICD system. This device, manufactured by Boston Scientific (Natick, MA), represents the first commercially available subcutaneous implantable defibrillator system (S-ICD) for the treatment of patients at risk for sudden cardiac arrest.

Sudden cardiac arrest involves the abrupt onset of a lethal heart rhythm. Most episodes are caused by the rapid and/or chaotic activity of the heart’s muscle and are known as ventricular tachycardia or ventricular fibrillation.

“The subcutaneous ICD system represents a significant advancement in therapy for patients at risk of sudden cardiac arrest. The ability to provide effective defibrillation without the need to access the vascular system offers particular advantages in certain selected patients,” said Orange Regional Medical Center Cardiologist, Paul Eugenio, MD. “Orange Regional Medical Center is among the first institutions in the Hudson Valley to have implanted this system and is proud to offer this innovative therapy.”

The S-ICD System is designed to provide the same protection from sudden cardiac arrest as the traditional transvenous implantable cardioverter-defibrillator (ICD). The advantage of this entirely subcutaneous system involves its ability to be implanted just below the skin without the need for thin, insulated wires – known as leads – to be placed into the heart itself (as is necessary with the standard transvenous ICD system). This leaves the heart and blood vessels untouched while still providing protections against lethal cardiac arrhythmias.

The S-ICD System has two main components: (1) the pulse generator, which powers the system, monitors heart activity, and delivers a shock if needed, and (2) the electrode, which enables the device to sense the cardiac rhythm and serves as a pathway for shock delivery when necessary. Both components are implanted just under the skin—the generator at the side of the chest, and the electrode beside the breastbone. Implantation of the S-ICD system is generally straightforward and can be done using only anatomical landmarks which removes the need for fluoroscopy (an X-ray procedure that is required for standard leads to be placed in the heart).

The Orange Regional Medical Center Cardiac Catheterization Laboratory, affiliated with Westchester Medical Center, offers three highly equipped, state-of-the-art cath labs where implantation of the S-ICD system is performed by our team of cardiac electrophysiologists.

For more information on the Peter Frommer, M.D. Heart Center at Orange Regional Medical Center or the S-ICD System, visit www.ormcheartcare.org.

Dr. Paul Eugenio
Dr. Paul Eugenio

Categories: News & MediaTags

Related Post